✦ LIBER ✦

Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study

✍ Scribed by Luísa Hoffmann, Juliene Antonio Ramos, Elizabeth Valentin de Souza…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

13 COMBINATION OF THE NS5A INHIBITOR, GS

✍ Everson, G.T.; Di Bisceglie, A.M.; Vierling, J.M.; Hsieh, F.; Trenkle, J.D.; Kan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Rapid, early and sustained virological r

✍ S. Sarwar; E. J. Ryan; M. Iqbal; P. A. McCormick; C. O’Farrelly; J. Hegarty 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Prevalence of hepatitis C virus variants

✍ Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Yuya Seko; Yusuke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Characterization of vaniprevir, a hepati

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Su1067 Drug Resistance Mutations in the

✍ Hayashi, Kazuhiko; Ishigami, Masatoshi; Ishizu, Yoji; Kuzuya, Teiji; Honda, Taka 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 243 KB

271 EXTENDED TREATMENT OF TREATMENT-NAIV

✍ C.M. Lange; H. Farnik; C. Sarrazin; B. Kronenberger; S. Zeuzem; E. Herrmann 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB